Antiverse
Develops therapeutic antibodies for challenging disease targets using AI-driven techbio
$9.3MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops therapeutic antibodies for challenging disease targets using AI-driven techbio
Develops human-based preclinical platform for drug safety and efficacy testing